Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
QuintilesIMS
Boehringer Ingelheim
Fuji
McKinsey
Queensland Health
Fish and Richardson
Argus Health
Deloitte

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,422,368

« Back to Dashboard

Summary for Patent: 5,422,368
Title: Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
Abstract:The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
Inventor(s): Stjernschantz; Johan W. (Upsala, SE), Resul; Bahram (Upsala, SE)
Assignee: Kabi Pharmacia AB (Upsala, SE)
Application Number:07/986,943
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 5,422,368

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,422,368

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8803110Sep 06, 1988
Sweden8803855Oct 28, 1988
PCT/SE89/00475Sep 06, 1989

International Patents Family Members for US Patent 5,422,368

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 101342 ➤ Sign Up
Austria 227576 ➤ Sign Up
Austria 420857 ➤ Sign Up
Australia 4189889 ➤ Sign Up
Australia 625096 ➤ Sign Up
Brazil 1100030 ➤ Sign Up
Germany 03014533 ➤ Sign Up
Germany 1300150 ➤ Sign Up
Germany 68913000 ➤ Sign Up
Germany 68929435 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Moodys
Accenture
Boehringer Ingelheim
Mallinckrodt
Fish and Richardson
Chinese Patent Office
Healthtrust
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot